直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

European IP Blog

No More Automatic COVID-19 Extensions at the EPO

June 1, 2020

Authored and Edited by K. Victoria Barker, Ph.D.; Nicholas Russell Philip Fox

In recent months, the EPO has announced various “COVID-19” extensions of time, allowing additional time for responding to certain time periods (see our blog post here). The final “COVID-19” extension period expires 2 June 2020, but most workplaces are still a long way from being back to “normal”. What does the absence of a formal COVID-19 extension mean for EPO users?

As noted in our previous blog post on this topic, many significant deadlines were excluded from this extension including the deadline for filing a divisional application, and the deadlines for filing written submissions.

Rather than providing a blanket extension of time for most (but not all) EPO time periods, the expiry of the “COVID-19” extensions of time means that if a time limit is now missed after 2 June 2020, the onus is on applicants to demonstrate that the time limit is missed due to a dislocation in the delivery or transmission of mail caused by an exceptional occurrence affecting the locality where an applicant, a party or their representative resides or has his place of business. If there is disruption due to the pandemic, and any document received late will be deemed to have been received in due time if the person concerned offers evidence that on any of the ten days preceding the day of expiry of a period, it was not possible to observe the time limit due to this exceptional occurrence and that the mailing or the transmission was effected at the latest on the fifth day after the end of the disruption.

Hence the main difference between the current situation and the situation prior to 2 June is that the EPO must now be presented with evidence that it was not possible to meet the time period. In accordance with J 13/05, the burden of proof to provide evidence of the dislocation of mail falls with the party requesting the remedy. While requests under Rule 134(5) EPC do not need to meet the “all due care” standard required for re-establishment of rights, there is no guarantee that a request will be granted.

It is not clear how many applicants were taking advantage of the previous extension regime. Given that it is possible to file documents with the EPO electronically, probably the new arrangements will limit extension to circumstance where due to the prevailing COVID-19 situation, an applicant is physically prevented from filing a response to the EPO for example due to a need and an inability to access an office in order to submit a response.

For further advice, please contact your European representative.

Tags

COVID-19, European Patent Office (EPO)

Contacts

K. Victoria Barker, Ph.D.
Associate
London
+44 (0)20 7864 2822
Email

Copyright © 2020 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information. 

Related Insights

Conference

Patent Litigation Europe 2027

January 18-20, 2027

Amsterdam

Reception

2026 IPO Education Foundation Awards Dinner

December 15, 2026

Washington, DC

Panel Discussion

2026 Advanced Patent Law Institute

December 3-4, 2026

Stanford

Conference

IPBC Asia 2026

November 17-19, 2026

Tokyo

Conference

IAM Live: Trade Secret Strategy USA

November 1, 2026

San Jose

Charitable

2026 ALYN Hospital Wheels of Love Ride

November 8-12, 2026

Northern District

Conference

IAM Live: Navigating the UPC 2026

November 4, 2026

Paris

Conference

Life Sciences Patent Network North America Fall 2026

November 2-3, 2026

San Francisco

Conference

2026 ANA Masters of Advertising Law Conference

November 2-4, 2026

Huntington Beach

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP